Search Results - Silvia Bader‐Weder

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy

    An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy by Jennifer M. Kwon, Kapil Arya, Nancy L. Kuntz, Han C. Phan, Cory Sieburg, Kathryn J. Swoboda, Aravindhan Veerapandiyan, Beverly Assman, Silvia Bader‐Weder, Travis L. Dickendesher, Jennifer L. Hansen, Helen Lin, Ying Yan, Vamshi K. Rao

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment

    Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment by Eugenio Mercuri, Giovanni Baranello, Odile Boespflug‐Tanguy, Liesbeth De Waele, Nathalie Goemans, Janbernd Kirschner, Riccardo Masson, Elena Mazzone, Astrid Pechmann, Maria Carmela Pera, Carole Vuillerot, Silvia Bader‐Weder, Marianne Gerber, Ksenija Gorni, Janine Hoffart, Heidemarie Kletzl, Carmen Martín, Tammy McIver, R. Scalco, Wai Yin Yeung, Laurent Servais

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: